Development and evaluation of perioperative comprehensive intervention to improve cardiopulmonary function and quality of life among lung cancer patients
Not Applicable
Recruiting
- Conditions
- Neoplasms
- Registration Number
- KCT0003228
- Lead Sponsor
- Samsung Medical Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 176
Inclusion Criteria
Patients with non-small cell lung cancer who are scheduled for a surgical resection as a primary treatment
- Patients who are able to walk and living a daily life
- Patients who understand the contents of questionnaire and agree to participate in the study
Exclusion Criteria
- Patients who are unable to walk
- Patients who have been diagnosed with cancer in the last 3 years
- Patients who underwent neoadjuvant or adjuvant chemotherapy and/or radiotherapy
- Patients with confirmed metastatic, recurrent, or multiple cancer
- Patients with confirmed benign tumors
- Patients who fails to perform the pre-operative measurement due to change in the date of surgery or refusal
Study & Design
- Study Type
- Interventional Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Symptoms (dyspnea, pain, fatigue);Quality of life (including lung cancer-specific quality of life)
- Secondary Outcome Measures
Name Time Method Postoperative complications